Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

80 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
9-[2-(Phosphonomethoxy)propyl]adenine therapy of established simian immunodeficiency virus infection in infant rhesus macaques.
Van Rompay KK, Cherrington JM, Marthas ML, Berardi CJ, Mulato AS, Spinner A, Tarara RP, Canfield DR, Telm S, Bischofberger N, Pedersen NC. Van Rompay KK, et al. Among authors: tarara rp. Antimicrob Agents Chemother. 1996 Nov;40(11):2586-91. doi: 10.1128/AAC.40.11.2586. Antimicrob Agents Chemother. 1996. PMID: 8913470 Free PMC article.
Biological effects of short-term or prolonged administration of 9-[2-(phosphonomethoxy)propyl]adenine (tenofovir) to newborn and infant rhesus macaques.
Van Rompay KK, Brignolo LL, Meyer DJ, Jerome C, Tarara R, Spinner A, Hamilton M, Hirst LL, Bennett DR, Canfield DR, Dearman TG, Von Morgenland W, Allen PC, Valverde C, Castillo AB, Martin RB, Samii VF, Bendele R, Desjardins J, Marthas ML, Pedersen NC, Bischofberger N. Van Rompay KK, et al. Antimicrob Agents Chemother. 2004 May;48(5):1469-87. doi: 10.1128/AAC.48.5.1469-1487.2004. Antimicrob Agents Chemother. 2004. PMID: 15105094 Free PMC article.
The clinical benefits of tenofovir for simian immunodeficiency virus-infected macaques are larger than predicted by its effects on standard viral and immunologic parameters.
Van Rompay KK, Singh RP, Brignolo LL, Lawson JR, Schmidt KA, Pahar B, Canfield DR, Tarara RP, Sodora DL, Bischofberger N, Marthas ML. Van Rompay KK, et al. Among authors: tarara rp. J Acquir Immune Defic Syndr. 2004 Aug 1;36(4):900-14. doi: 10.1097/00126334-200408010-00003. J Acquir Immune Defic Syndr. 2004. PMID: 15220696
Early short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine treatment favorably alters the subsequent disease course in simian immunodeficiency virus-infected newborn Rhesus macaques.
van Rompay KK, Dailey PJ, Tarara RP, Canfield DR, Aguirre NL, Cherrington JM, Lamy PD, Bischofberger N, Pedersen NC, Marthas ML. van Rompay KK, et al. Among authors: tarara rp. J Virol. 1999 Apr;73(4):2947-55. doi: 10.1128/JVI.73.4.2947-2955.1999. J Virol. 1999. PMID: 10074144 Free PMC article.
9-[2-(Phosphonomethoxy)propyl]adenine (PMPA) therapy prolongs survival of infant macaques inoculated with simian immunodeficiency virus with reduced susceptibility to PMPA.
Van Rompay KK, Cherrington JM, Marthas ML, Lamy PD, Dailey PJ, Canfield DR, Tarara RP, Bischofberger N, Pedersen NC. Van Rompay KK, et al. Among authors: tarara rp. Antimicrob Agents Chemother. 1999 Apr;43(4):802-12. doi: 10.1128/AAC.43.4.802. Antimicrob Agents Chemother. 1999. PMID: 10103184 Free PMC article.
Prophylactic and therapeutic benefits of short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) administration to newborn macaques following oral inoculation with simian immunodeficiency virus with reduced susceptibility to PMPA.
Van Rompay KK, Miller MD, Marthas ML, Margot NA, Dailey PJ, Canfield DR, Tarara RP, Cherrington JM, Aguirre NL, Bischofberger N, Pedersen NC. Van Rompay KK, et al. Among authors: tarara rp. J Virol. 2000 Feb;74(4):1767-74. doi: 10.1128/jvi.74.4.1767-1774.2000. J Virol. 2000. PMID: 10644348 Free PMC article.
80 results